Skip to main content

Table 1 Baseline characteristics of the cohort and between the two groups

From: Longitudinal changes in ventricular volume after treating aqueduct stenosis through endoscopic third ventriculostomy in adults

Variables

Total

Successful-ETV

Failed-ETV

P value

Number of patients

46

39 (84.8)

7 (15.2)

 

Mean age ± SD, years

50.4 ± 20.7

52.2 ± 21.6

40.4 ± 11.7

0.278

Females

28 (60.9)

23 (59)

5 (71.4)

0.534

mRS at baseline

   

0.928

 ≤ 2

27 (58.7)

23 (59)

4 (57.1)

 

 > 2

19 (41.3)

16 (41)

3 (42.9)

 

Etiology for Aqueduct stenosis

   

0.436

 Membrane

24 (52.2)

20 (51.3)

4 (57.1)

 

 Lesion/Tumor pineal or tectal region

16 (34.8)

14 (35.9)

2 (28.6)

 

 Pineal cyst

4 (8.7)

4 (10.3)

-

 

 Occlusion/Stenosis without membrane

2 (4.3)

1 (2.6)

1 (14.3)

 

Procedure type

   

0.71

 ETV

35 (76.1)

29 (74.4)

6 (85.7)

 

 ETV + Endoscopic biopsy

8 (17.4)

7 (17.9)

1 (14.3)

 

 ETV + Endoscopic cyst fenestration

3 (6.5)

3 (7.7)

-

 

Radiology preoperatively

    

 Evans Index ± SD

0.36 ± 0.06

0.37 ± 0.06

0.36 ± 0.04

0.929

 FOHR ± SD

0.48 ± 0.06

0.48 ± 0.06

0.48 ± 0.06

1

 Volume lateral ventricles, cm3

171 ± 182.1

172.3 ± 192.1

163.9 ± 123

0.905

 Volume 3rd ventricle, cm3

5.8 ± 3.4

5.9 ± 3.6

5.4 ± 2

0.891

 Volume 4th ventricle, cm3

1.3 ± 1

1.3 ± 1.1

1.2 ± 0.7

0.902

 Volume lateral and 3rd ventricles, cm3

176.8 ± 184.9

178.2 ± 195.1

169.2 ± 123.7

0.891

  1. SD = standard deviation, mRS = modified Rankin Score, ETV = Endoscopic third ventriculostomy, FOHR = Frontal occipital horn ratio
  2. All values presented as number (%) of patients or mean ± SD, if not otherwise specified